If hunger has returned, the patient may need satiety-focused nutrition, meal timing, fiber, and a realistic plan for cravings
Additionally, retatrutide also shows functions in mitigating cardiovascular risk factors and addressing metabolic dysfunction-associated steatotic liver disease
This guidance follows the FDAs approval of Wegovy (semaglutide) for an expanded indication to reduce the risk of major cardiovascular events (MACE), including cardiovascular death, non-fatal myocardial infarction, and non-fatal stroke in adults with established cardiovascular disease (CVD) and who are either obese or overweight
The dietitian behind your daily guidance
Once you open a vial and begin injections, the shelf life shortens further
FDA-approved versions like Wegovy and Zepbound have gone through rigorous review processes